Phibro's CEO transition puts this insider sale in context

23.05.26 23:07 Uhr

Werte in diesem Artikel
Aktien

7,68 EUR -0,46 EUR -5,65%

Jack Bendheim, President and CEO of Phibro Animal Health Corporation (NASDAQ:PAHC), disclosed the indirect sale of 18,608 shares of Common Stock across multiple open-market transactions from May 5, 2026 through May 7, 2026, as reported in the SEC Form 4 filing.Transaction value based on SEC Form 4 weighted average purchase price ($54.61); post-transaction value based on total reported shares multiplied by the final May 7, 2026 close price, as calculated in SEC data.* 1-year performance calculated using May 7th, 2026 as the reference date.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Quelle: MotleyFool

Nachrichten zu Transition